Fig. 1From: Impact of C-reactive protein on the effect of Roxadustat for the treatment of anemia in chronic kidney disease: a systematic review of randomized controlled trialsPRISMA 2020 flow diagram. ICTRP, International Clinical Trials Registry Platform; RCT, randomized-controlled trialsBack to article page